指南与共识流行病学与生物统计医学教育与科研方法

法国2型糖尿病HbA1c管理推荐所用随机试验的实用性评估:PRECIS-2工具应用

How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool.
指南 / 共识 · Trials · 2020-03-19

该研究用PRECIS-2工具评估2013年法国High Authority of Health关于2型糖尿病管理推荐所依据的随机试验的实用性。政策制定者应资助实用性试验以提供可行推荐。

要点

  • 法国2型糖尿病HbA1c管理推荐所依据的试验多为解释性设计,实用性不足。
  • PRECIS-2九领域中八个中位评分低于3分,仅主要分析领域评分为4分。
  • 超25%文章在招募、实施灵活性、依从灵活性和主要分析领域数据缺失。

核心结论

  • 用于构建法国初级保健2型糖尿病管理推荐的试验更偏向解释性而非实用性。

研究设计与样本

  • 由两名盲法研究者按PRECIS-2九领域各评1至5分,分歧时由第三名研究者共识。

主要发现

  • 九领域中八个(资格、招募、环境、组织、实施灵活性、依从灵活性、随访、主要结局)中位评分低于3分,提示更解释性设计。
  • 仅主要分析领域中位评分为4分,提示更实用方法。
  • 超过25%的文章在招募、实施灵活性、依从灵活性和主要分析领域缺少评分数据。

关键数值与推荐

  • PRECIS-2每个领域评分1分(非常解释性)至5分(非常实用性)。
  • 中位评分低于3分判定为更解释性设计,主要分析领域中位评分为4分判定为更实用方法。

临床怎么用

  • 初级保健临床医生应用法国2型糖尿病HbA1c管理推荐时,需注意其证据多来自解释性试验。
  • 政策制定者应鼓励资助实用性试验,以评估根据HbA1c水平管理患者治疗的不同策略。

局限性

  • 超过25%的文章在招募、实施灵活性、依从灵活性和主要分析领域缺少评分数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recommendations for good clinical practice have been reported to be difficult to apply in real life by primary care clinicians. This could be because the clinical trials at the origin of the guidelines are based on explanatory trials, conducted under ideal conditions not reflecting the reality of primary care, rather than pragmatic trials conducted under real-life conditions. The objective of this study was to evaluate how pragmatic are the clinical trials used to build the French High Authority of Health's recommendations on the management of type II diabetes. METHODS: Trials from the 2013 Cochrane meta-analysis that led to the 2013 French High Authority of Health's recommendations on the management of type II diabetes were selected. Each trial was analysed by applying the PRECIS-2 tool to evaluate whether the trial was pragmatic or explanatory, according to the nine domains of PRECIS-2. Each domain was scored between 1 (very explanatory) and 5 (very pragmatic) by two blinded researchers, and consensus was reached with a third researcher in case of discrepancy. Median scores were calculated for each of the nine domains. RESULTS: Twenty-three articles were analysed. Eight out of nine domains - namely eligibility, recruitment, setting, organisation, flexibility of delivery, flexibility of adherence, follow-up, and primary outcome - had a median score of less than 3, indicating a more explanatory design. Only the primary analysis domain had a score indicating a more pragmatic approach (median score of 4). In more than 25% of the articles, data to score the domains of recruitment, flexibility of delivery, flexibility of adherence, and primary analysis were missing. CONCLUSIONS: Trials used to build French recommendations for good clinical practice for the management of type 2 diabetes in primary care were more explanatory than pragmatic. Policy-makers should encourage the funding of pragmatic trials to evaluate the different strategies proposed for managing the patient's treatment according to HbA1C levels and give clinicians feasible recommendations.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ettori-Ajasse I, Tatin E, Forbes G, et al. How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool. Trials. 2020. PMID: 32188470. doi:10.1186/s13063-020-4215-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。